Skip to main content
. 2022 Aug 30;11(17):5087. doi: 10.3390/jcm11175087

Table 3.

Comparison of routine laboratory parameters between ILD progressors and non progressors.

ILD Progressors (N = 19) ILD Non Progressors (N = 121) p
White blood cells G/L 7.4 (5.8; 9.1) 7.1 (5.8; 8.8) 0.69
Monocytes G/L 0.7 (0.6; 1.0) 0.6 (0.5; 0.8) 0.028
Neutrophils G/L 4.5 (3.3; 6.4) 4.4 (3.5; 5.6) 0.90
Eosinophils G/L 0.2 (0.1; 0.2) 0.2 (0.1; 0.3) 0.93
Lymphocytes G/L 1.6 (1.2; 2.0) 1.6 (1.2; 2.3) 1.00
Basophils G/L 0.0 (0.0; 0.1) 0.0 (0.0; 0.1) 0.59
Hemoglobin g/dL 13.9 (12.8; 14.7) 13.1 (12.4; 14.2) 0.12
Platelets G/L 243.0 (221.0; 291.5) 273.0 (230.0; 314.0) 0.60
CRP mg/L 4.0 (3.0; 5.0) 3.0 (3.0; 5.0) 0.29
ESR mm/h 9.0 (5.5; 22.0) 10.0 (6.0; 22.0) 0.93
NT pro BNP ng/L 113.0 (67.0; 291.0) 97.0 (55.0; 248.0) 0.51
Ferritin ng/mL 99.0 (61.5; 151.0) 70.0 (29.0; 129.0) 0.094
Uric acid mg/L 48.0 (40.0; 59.0) 46.5 (35.0; 56.0) 0.59
AST UI/L 23.0 (19.5; 28.5) 21.0 (18.0; 25.0) 0.37
ALT UI/L 18.0 (13.5; 22.5) 16.0 (12.0; 22.0) 0.59
ALP UI/L 58.0 (52.5; 94.5) 62.0 (52.0; 79.0) 0.90
GGT UI/L 29.0 (22.0; 50.0) 21.5 (15.0; 43.0) 0.13
Total bilirubin mg/L 4.5 (3.0; 6.5) 3.0 (3.0; 5.0) 0.099
Serum sodium mmol/L 140.0 (139.0; 141.0) 140.0 (139.0; 141.0) 0.95
Serum potassium mmol/L 4.2 (4.0; 4.4) 4.2 (4.0; 4.5) 0.37
Urea g/L 0.3 (0.3; 0.4) 0.3 (0.3; 0.4) 0.70
Creatinin mg/L 8.0 (7.0; 9.0) 8.0 (7.0; 9.0) 0.89
A1globulins g/L 3.0 (2.8; 3.4) 3.0 (2.6; 3.3) 0.45
A2globulins g/L 8.0 (7.4; 8.6) 7.7 (6.9; 8.4) 0.64
Beta globulins g/L 7.5 (6.8; 8.3) 7.8 (7.2; 8.4) 0.29
Gamma globulins g/L 9.0 (8.0; 10.3) 10.1 (7.9; 12.2) 0.24
Albumin g/L 40.2 (38.0; 43.1) 40.1 (38.0; 43.1) 0.54

Values are presented as median (interquartile range); CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; ALP: alkaline phosphatase; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gammaglutamyltranspeptidase; NTproBNP: N-terminal pro-brain natriuretic peptide; G/L: Giga/Liter. p value < 0.05 (significant results appear in bold in the table). A1 globulins: alpha 1 globulins; A2 globulins: alpha 2 globulins; 6 patients had a missing FVC value (1 at baseline and 5 at follow up) precluding their classification as either progressors or non progressors.